Abdul Mannan: Postpartum Bleeding Is Not Always Obstetric Bleeding
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
”Postpartum bleeding is not always obstetric bleeding.
An isolated prolonged APTT is a diagnostic alarm, not a laboratory nuisance.
Pregnancy-associated acquired haemophilia A is rare, but it often presents weeks after delivery, when the patient has left maternity care.
For trainees and front-line teams, the first move is simple:
- Ask why the APTT is prolonged
- Send FVIII activity and a Nijmegen Bethesda inhibitor assay early
- In active bleeding, involve the haemophilia centre and specialist coagulation laboratory
- Control active bleeding and eradicate the inhibitor as linked, but separate, goals
Emicizumab now belongs in this conversation.
It is a specialist-selected option to prevent further bleeding in acquired haemophilia A, especially when immunosuppression is delayed or not feasible.
But it does not eradicate the inhibitor. And if it is used, laboratory monitoring must change: use a bovine chromogenic inhibitor assay.
For pregnancy and breastfeeding, be honest about the evidence gap.
The 2023 GTH-AHA-EMI study was not pregnancy-specific.
A 2026 postpartum case found emicizumab in breast milk, but we still do not know the clinical effect of infant exposure.
The practical message: do not miss the APTT, do not delay specialist input, and do not let a new therapy blur the difference between haemostatic protection and inhibitor eradication.
How does your maternity, emergency or coagulation service flag delayed postpartum bleeding with an isolated prolonged APTT?
Evidence: Percy et al., British Journal of Haematology 2026; Tiede et al., Lancet Haematology 2023; Dewarrat et al., Haemophilia 2021; Krooss et al., Journal of Thrombosis and Haemostasis 2026.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma